nodes	percent_of_prediction	percent_of_DWPC	metapath
Amrinone—TNF—Canonical NF-kappaB pathway—BCL10—colon cancer	0.0459	0.0459	CbGpPWpGaD
Amrinone—TNF—Caspase Cascade in Apoptosis—TOP1—colon cancer	0.0354	0.0354	CbGpPWpGaD
Amrinone—TNF—Overview of nanoparticle effects—BAX—colon cancer	0.0289	0.0289	CbGpPWpGaD
Amrinone—TNF—Transcription factor regulation in adipogenesis—PPARG—colon cancer	0.0189	0.0189	CbGpPWpGaD
Amrinone—TNF—Overview of nanoparticle effects—PTGS2—colon cancer	0.0167	0.0167	CbGpPWpGaD
Amrinone—TNF—Amyotrophic lateral sclerosis (ALS)—BAX—colon cancer	0.0166	0.0166	CbGpPWpGaD
Amrinone—TNF—RXR and RAR heterodimerization with other nuclear receptor—PPARG—colon cancer	0.0165	0.0165	CbGpPWpGaD
Amrinone—TNF—Amyotrophic lateral sclerosis (ALS)—BCL2L1—colon cancer	0.0144	0.0144	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	0.0143	0.0143	CbGpPWpGaD
Amrinone—TNF—Ceramide signaling pathway—BAX—colon cancer	0.0138	0.0138	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.0135	0.0135	CbGpPWpGaD
Amrinone—TNF—Caspase Cascade in Apoptosis—BAX—colon cancer	0.012	0.012	CbGpPWpGaD
Amrinone—TNF—Apoptosis—DCC—colon cancer	0.0108	0.0108	CbGpPWpGaD
Amrinone—TNF—Downstream signaling in naïve CD8+ T cells—CD8A—colon cancer	0.0108	0.0108	CbGpPWpGaD
Amrinone—TNF—Caspase Cascade in Apoptosis—BCL2L1—colon cancer	0.0104	0.0104	CbGpPWpGaD
Amrinone—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CASP3—colon cancer	0.00998	0.00998	CbGpPWpGaD
Amrinone—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—colon cancer	0.0098	0.0098	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—ABCB1—colon cancer	0.00977	0.00977	CbGpPWpGaD
Amrinone—TNF—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—colon cancer	0.00941	0.00941	CbGpPWpGaD
Amrinone—TNF—IL27-mediated signaling events—TGFB1—colon cancer	0.00941	0.00941	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.00918	0.00918	CbGpPWpGaD
Amrinone—TNF—Cytokines and Inflammatory Response—TGFB1—colon cancer	0.00913	0.00913	CbGpPWpGaD
Amrinone—TNF—Amyotrophic lateral sclerosis (ALS)—CASP3—colon cancer	0.00892	0.00892	CbGpPWpGaD
Amrinone—TNF—Apoptosis—BAX—colon cancer	0.0088	0.0088	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	0.00824	0.00824	CbGpPWpGaD
Amrinone—TNF—TWEAK Signaling Pathway—CASP3—colon cancer	0.00823	0.00823	CbGpPWpGaD
Amrinone—TNF—FAS pathway and Stress induction of HSP regulation—CASP3—colon cancer	0.00823	0.00823	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—BAX—colon cancer	0.00818	0.00818	CbGpPWpGaD
Amrinone—TNF—TWEAK Signaling Pathway—CTNNB1—colon cancer	0.00793	0.00793	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.00773	0.00773	CbGpPWpGaD
Amrinone—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—colon cancer	0.00771	0.00771	CbGpPWpGaD
Amrinone—TNF—Downstream signaling in naïve CD8+ T cells—BRAF—colon cancer	0.00765	0.00765	CbGpPWpGaD
Amrinone—TNF—Apoptosis—BCL2L1—colon cancer	0.00764	0.00764	CbGpPWpGaD
Amrinone—TNF—Signaling events mediated by HDAC Class I—PPARG—colon cancer	0.00749	0.00749	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	0.00721	0.00721	CbGpPWpGaD
Amrinone—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—colon cancer	0.00716	0.00716	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—BCL2L1—colon cancer	0.00711	0.00711	CbGpPWpGaD
Amrinone—TNF—Transcriptional regulation of white adipocyte differentiation—PPARG—colon cancer	0.00694	0.00694	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	0.00686	0.00686	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—EP300—colon cancer	0.00686	0.00686	CbGpPWpGaD
Amrinone—TNF—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—colon cancer	0.00674	0.00674	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—SRC—colon cancer	0.00667	0.00667	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	0.00667	0.00667	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	0.00649	0.00649	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—CTNNB1—colon cancer	0.00649	0.00649	CbGpPWpGaD
Amrinone—TNF—Caspase Cascade in Apoptosis—CASP3—colon cancer	0.00645	0.00645	CbGpPWpGaD
Amrinone—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—CDKN1A—colon cancer	0.00643	0.00643	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—NRAS—colon cancer	0.00641	0.00641	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.00618	0.00618	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—PIK3CA—colon cancer	0.00604	0.00604	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—EP300—colon cancer	0.00603	0.00603	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—MYC—colon cancer	0.00597	0.00597	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	0.00596	0.00596	CbGpPWpGaD
Amrinone—PDE4B—G Protein Signaling Pathways—NRAS—colon cancer	0.00589	0.00589	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—EGFR—colon cancer	0.00584	0.00584	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	0.00584	0.00584	CbGpPWpGaD
Amrinone—TNF—Ceramide signaling pathway—MYC—colon cancer	0.00577	0.00577	CbGpPWpGaD
Amrinone—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—colon cancer	0.00572	0.00572	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—KRAS—colon cancer	0.00552	0.00552	CbGpPWpGaD
Amrinone—TNF—Apoptosis—BAX—colon cancer	0.00539	0.00539	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—TGFB1—colon cancer	0.00524	0.00524	CbGpPWpGaD
Amrinone—TNF—Cardiac Hypertrophic Response—TGFB1—colon cancer	0.00517	0.00517	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—DLC1—colon cancer	0.00512	0.00512	CbGpPWpGaD
Amrinone—PDE4B—G Protein Signaling Pathways—KRAS—colon cancer	0.00507	0.00507	CbGpPWpGaD
Amrinone—TNF—Alzheimers Disease—CASP3—colon cancer	0.00496	0.00496	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—CASP3—colon cancer	0.00496	0.00496	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—PTGS2—colon cancer	0.00491	0.00491	CbGpPWpGaD
Amrinone—TNF—Signaling events mediated by HDAC Class I—EP300—colon cancer	0.0049	0.0049	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—DLC1—colon cancer	0.00487	0.00487	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.00482	0.00482	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—LGR5—colon cancer	0.00482	0.00482	CbGpPWpGaD
Amrinone—TNF—Downstream signaling in naïve CD8+ T cells—NRAS—colon cancer	0.00481	0.00481	CbGpPWpGaD
Amrinone—TNF—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—colon cancer	0.00474	0.00474	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.00474	0.00474	CbGpPWpGaD
Amrinone—TNF—Apoptosis—CASP3—colon cancer	0.00473	0.00473	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—HRAS—colon cancer	0.00469	0.00469	CbGpPWpGaD
Amrinone—TNF—Apoptosis—BCL2L1—colon cancer	0.00468	0.00468	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—LGR5—colon cancer	0.00458	0.00458	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—PPARG—colon cancer	0.00456	0.00456	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.00456	0.00456	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—CTNNB1—colon cancer	0.00456	0.00456	CbGpPWpGaD
Amrinone—TNF—Transcriptional regulation of white adipocyte differentiation—EP300—colon cancer	0.00454	0.00454	CbGpPWpGaD
Amrinone—TNF—TWEAK Signaling Pathway—AKT1—colon cancer	0.00446	0.00446	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—CASP3—colon cancer	0.0044	0.0044	CbGpPWpGaD
Amrinone—PDE4B—G Protein Signaling Pathways—HRAS—colon cancer	0.00431	0.00431	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—DCC—colon cancer	0.00429	0.00429	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—VEGFA—colon cancer	0.00421	0.00421	CbGpPWpGaD
Amrinone—TNF—Downstream signaling in naïve CD8+ T cells—KRAS—colon cancer	0.00414	0.00414	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—HRAS—colon cancer	0.00413	0.00413	CbGpPWpGaD
Amrinone—TNF—Apoptosis—APC—colon cancer	0.00411	0.00411	CbGpPWpGaD
Amrinone—TNF—Ceramide signaling pathway—AKT1—colon cancer	0.004	0.004	CbGpPWpGaD
Amrinone—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—colon cancer	0.00395	0.00395	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—PTGS2—colon cancer	0.00388	0.00388	CbGpPWpGaD
Amrinone—TNF—Angiopoietin receptor Tie2-mediated signaling—AKT1—colon cancer	0.00388	0.00388	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—TGFB1—colon cancer	0.00387	0.00387	CbGpPWpGaD
Amrinone—TNF—Apoptosis—CDH1—colon cancer	0.00378	0.00378	CbGpPWpGaD
Amrinone—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—AKT1—colon cancer	0.0037	0.0037	CbGpPWpGaD
Amrinone—TNF—Apoptosis—MYC—colon cancer	0.00369	0.00369	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—NRAS—colon cancer	0.00368	0.00368	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—colon cancer	0.00368	0.00368	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—TP53—colon cancer	0.00368	0.00368	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—BRAF—colon cancer	0.00362	0.00362	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—HNF4A—colon cancer	0.00361	0.00361	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—CASP3—colon cancer	0.0036	0.0036	CbGpPWpGaD
Amrinone—TNF—Cardiac Hypertrophic Response—AKT1—colon cancer	0.00359	0.00359	CbGpPWpGaD
Amrinone—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—colon cancer	0.00352	0.00352	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—CCND1—colon cancer	0.00351	0.00351	CbGpPWpGaD
Amrinone—TNF—Caspase Cascade in Apoptosis—AKT1—colon cancer	0.00349	0.00349	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.00348	0.00348	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—AXIN2—colon cancer	0.00346	0.00346	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—AXIN2—colon cancer	0.00329	0.00329	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—CTNNB1—colon cancer	0.00321	0.00321	CbGpPWpGaD
Amrinone—TNF—Alzheimers Disease—TP53—colon cancer	0.00318	0.00318	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—KRAS—colon cancer	0.00317	0.00317	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—CDKN1A—colon cancer	0.00314	0.00314	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—PIK3CA—colon cancer	0.00313	0.00313	CbGpPWpGaD
Amrinone—TNF—Apoptosis—TP53—colon cancer	0.00303	0.00303	CbGpPWpGaD
Amrinone—TNF—Apoptosis—CASP3—colon cancer	0.0029	0.0029	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—CASP3—colon cancer	0.00288	0.00288	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—MYC—colon cancer	0.00281	0.00281	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—TGFB1—colon cancer	0.00281	0.00281	CbGpPWpGaD
Amrinone—TNF—Apoptosis—CTNNB1—colon cancer	0.00279	0.00279	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.00278	0.00278	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—EGFR—colon cancer	0.00275	0.00275	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—CASP3—colon cancer	0.00271	0.00271	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—HRAS—colon cancer	0.0027	0.0027	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—PIK3CA—colon cancer	0.00268	0.00268	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.00264	0.00264	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—TGFB1—colon cancer	0.0026	0.0026	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—EP300—colon cancer	0.00258	0.00258	CbGpPWpGaD
Amrinone—TNF—Apoptosis—AKT1—colon cancer	0.00256	0.00256	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—AKT1—colon cancer	0.00256	0.00256	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.00245	0.00245	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—VEGFA—colon cancer	0.00244	0.00244	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.00238	0.00238	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—AKT1—colon cancer	0.00238	0.00238	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.00236	0.00236	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—TP53—colon cancer	0.00231	0.00231	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.00231	0.00231	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—NRAS—colon cancer	0.00228	0.00228	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.0022	0.0022	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—AKT1—colon cancer	0.00219	0.00219	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.00213	0.00213	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—MYC—colon cancer	0.00212	0.00212	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—TGFB1—colon cancer	0.00211	0.00211	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—PIK3CA—colon cancer	0.00209	0.00209	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.00208	0.00208	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—EGFR—colon cancer	0.00207	0.00207	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—KRAS—colon cancer	0.00196	0.00196	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.00191	0.00191	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.00191	0.00191	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.00187	0.00187	CbGpPWpGaD
Amrinone—TNF—Apoptosis—TP53—colon cancer	0.00186	0.00186	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.00177	0.00177	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—TP53—colon cancer	0.00174	0.00174	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—AKT1—colon cancer	0.00171	0.00171	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—EP300—colon cancer	0.00171	0.00171	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—SRC—colon cancer	0.00166	0.00166	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.00162	0.00162	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—VEGFA—colon cancer	0.00162	0.00162	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—NRAS—colon cancer	0.0016	0.0016	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.00157	0.00157	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—PPARG—colon cancer	0.00157	0.00157	CbGpPWpGaD
Amrinone—TNF—Apoptosis—AKT1—colon cancer	0.00157	0.00157	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—TGFB1—colon cancer	0.00149	0.00149	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—AKT1—colon cancer	0.00147	0.00147	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—KRAS—colon cancer	0.00138	0.00138	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.00133	0.00133	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—PIK3CA—colon cancer	0.00126	0.00126	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—TP53—colon cancer	0.00122	0.00122	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—HRAS—colon cancer	0.00117	0.00117	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—CTNNB1—colon cancer	0.0011	0.0011	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—AKT1—colon cancer	0.00103	0.00103	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—EP300—colon cancer	0.00103	0.00103	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—FGFR3—colon cancer	0.000999	0.000999	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—SRC—colon cancer	0.000998	0.000998	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—VEGFA—colon cancer	0.000972	0.000972	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—NRAS—colon cancer	0.00096	0.00096	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—FGFR3—colon cancer	0.00095	0.00095	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—APC—colon cancer	0.000917	0.000917	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—NRAS—colon cancer	0.000917	0.000917	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—TGFB1—colon cancer	0.000892	0.000892	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—EGFR—colon cancer	0.000875	0.000875	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—APC—colon cancer	0.000872	0.000872	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—NRAS—colon cancer	0.000872	0.000872	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—BRAF—colon cancer	0.000862	0.000862	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—EGFR—colon cancer	0.000836	0.000836	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—KRAS—colon cancer	0.000826	0.000826	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—BRAF—colon cancer	0.00082	0.00082	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—PIK3CA—colon cancer	0.000799	0.000799	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—EGFR—colon cancer	0.000795	0.000795	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—KRAS—colon cancer	0.000789	0.000789	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—PIK3CA—colon cancer	0.00076	0.00076	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—KRAS—colon cancer	0.000751	0.000751	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—PIK3CA—colon cancer	0.000725	0.000725	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—HRAS—colon cancer	0.000702	0.000702	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—PIK3CA—colon cancer	0.00069	0.00069	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—HRAS—colon cancer	0.000671	0.000671	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—AKT1—colon cancer	0.000652	0.000652	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—CASP3—colon cancer	0.000646	0.000646	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—HRAS—colon cancer	0.000638	0.000638	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—CCND1—colon cancer	0.000629	0.000629	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—CTNNB1—colon cancer	0.000623	0.000623	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—AKT1—colon cancer	0.000621	0.000621	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—AKT1—colon cancer	0.00062	0.00062	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—CASP3—colon cancer	0.000615	0.000615	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—CDKN1A—colon cancer	0.000609	0.000609	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—CCND1—colon cancer	0.000598	0.000598	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—CTNNB1—colon cancer	0.000593	0.000593	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—AKT1—colon cancer	0.000592	0.000592	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—EP300—colon cancer	0.000579	0.000579	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—CDKN1A—colon cancer	0.000579	0.000579	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—AKT1—colon cancer	0.000564	0.000564	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—SRC—colon cancer	0.000563	0.000563	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—EP300—colon cancer	0.000551	0.000551	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—VEGFA—colon cancer	0.000549	0.000549	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—NRAS—colon cancer	0.000542	0.000542	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—SRC—colon cancer	0.000536	0.000536	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—VEGFA—colon cancer	0.000522	0.000522	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—NRAS—colon cancer	0.000515	0.000515	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—MYC—colon cancer	0.000505	0.000505	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—TGFB1—colon cancer	0.000503	0.000503	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—EGFR—colon cancer	0.000494	0.000494	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—MYC—colon cancer	0.00048	0.00048	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—TGFB1—colon cancer	0.000479	0.000479	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—EGFR—colon cancer	0.00047	0.00047	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—KRAS—colon cancer	0.000466	0.000466	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—KRAS—colon cancer	0.000444	0.000444	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—PIK3CA—colon cancer	0.000428	0.000428	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—TP53—colon cancer	0.000414	0.000414	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—PIK3CA—colon cancer	0.000408	0.000408	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—HRAS—colon cancer	0.000396	0.000396	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—TP53—colon cancer	0.000394	0.000394	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—HRAS—colon cancer	0.000377	0.000377	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—AKT1—colon cancer	0.00035	0.00035	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—AKT1—colon cancer	0.000333	0.000333	CbGpPWpGaD
